Cellectar Biosciences Inc (CLRB) — Financial Flexibility Index
Cellectar Biosciences Inc (CLRB) has a Financial Flexibility Index of -0.86x as of December 2025. Free cash flow of $-4.34 Million (operating CF $-4.34 Million minus capex $5.88K) represents -1% of total liabilities ($5.06 Million). Also explore Cellectar Biosciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cellectar Biosciences Inc Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Cellectar Biosciences Inc across 22 annual periods. Check CLRB strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cellectar Biosciences Inc (2004–2025)
Year-by-year free cash flow to debt coverage for Cellectar Biosciences Inc. For the full company profile including market capitalisation, see CLRB company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.57x | $-23.11 Million | $-23.12 Million | $5.06 Million | ▼ -7.6% |
| 2024 | -4.25x | $-47.48 Million | $-47.58 Million | $11.18 Million | ▼ -248.4% |
| 2023 | -1.22x | $-31.51 Million | $-32.38 Million | $25.85 Million | ▲ +41.2% |
| 2022 | -2.07x | $-25.00 Million | $-25.22 Million | $12.05 Million | ▲ +61.6% |
| 2021 | -5.40x | $-22.43 Million | $-22.57 Million | $4.16 Million | ▼ -50.3% |
| 2020 | -3.59x | $-13.87 Million | $-13.93 Million | $3.86 Million | ▲ +1.8% |
| 2019 | -3.66x | $-11.67 Million | $-11.69 Million | $3.19 Million | ▲ +40.7% |
| 2018 | -6.17x | $-11.06 Million | $-11.44 Million | $1.79 Million | ▼ -22.3% |
| 2017 | -5.04x | $-10.67 Million | $-11.02 Million | $2.12 Million | ▼ -9.6% |
| 2016 | -4.60x | $-8.21 Million | $-8.28 Million | $1.78 Million | ▼ -235.5% |
| 2015 | -1.37x | $-8.15 Million | $-8.21 Million | $5.95 Million | ▲ +58.4% |
| 2014 | -3.30x | $-8.81 Million | $-8.84 Million | $2.67 Million | ▼ -87.2% |
| 2013 | -1.76x | $-9.01 Million | $-9.15 Million | $5.12 Million | ▲ +64.2% |
| 2012 | -4.92x | $-6.49 Million | $-6.59 Million | $1.32 Million | ▲ +9.1% |
| 2011 | -5.41x | $-5.85 Million | $-5.97 Million | $1.08 Million | ▲ +13.1% |
| 2010 | -6.22x | $-7.80 Million | $-7.80 Million | $1.25 Million | ▼ -2003.5% |
| 2009 | -0.30x | $-10.60 Million | $-10.62 Million | $35.83 Million | ▲ +87.9% |
| 2008 | -2.45x | $-17.28 Million | $-17.33 Million | $7.05 Million | ▼ -209.6% |
| 2007 | -0.79x | $-13.44 Million | $-13.47 Million | $16.98 Million | ▲ +83.9% |
| 2006 | -4.92x | $-6.46 Million | $-6.47 Million | $1.31 Million | ▲ +55.0% |
| 2005 | -10.93x | $-2.37 Million | $-2.40 Million | $217.16K | ▼ -12417.6% |
| 2004 | -0.09x | $-389.17K | $-389.18K | $4.46 Million | — |